May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Retinal Degeneration in a Mouse Model of Retinitis Pigmentosa: Rpe65 as Modifier Gene and Role of Phototransduction, c–Fos, Caspase–1 and Prion Protein in the Degenerative Process
Author Affiliations & Notes
  • C. Grimm
    Ophthalmology, University Hospital Zurich, Zurich, Switzerland
  • A. Wenzel
    Ophthalmology, University Hospital Zurich, Zurich, Switzerland
  • M. Samardzija
    Ophthalmology, University Hospital Zurich, Zurich, Switzerland
  • R. Frigg
    Ophthalmology, University Hospital Zurich, Zurich, Switzerland
  • M. Naash
    Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma, OK
  • C. Reme
    Ophthalmology, University Hospital Zurich, Zurich, Switzerland
  • Footnotes
    Commercial Relationships  C. Grimm, None; A. Wenzel, None; M. Samardzija, None; R. Frigg, None; M. Naash, None; C. Reme, None.
  • Footnotes
    Support  SNF Grant 3100–064917.01; German Research Council; Velux Foundation Switzerland; NIH (EY10609);
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 3557. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Grimm, A. Wenzel, M. Samardzija, R. Frigg, M. Naash, C. Reme; Retinal Degeneration in a Mouse Model of Retinitis Pigmentosa: Rpe65 as Modifier Gene and Role of Phototransduction, c–Fos, Caspase–1 and Prion Protein in the Degenerative Process . Invest. Ophthalmol. Vis. Sci. 2005;46(13):3557.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Photoreceptor degeneration in the VPP mouse, a model for human RP, is accelerated by light exposure. Several factors are known to influence light–induced retinal degeneration in wild–type mice. With the generation of double mutant mice, we tested the role of such factors in the VPP mouse. Methods: VPP mice have three mutations at the N–terminus of the gene encoding rod opsin. These mice were crossed with several transgenic and mutant mouse strains to create double mutant mice. Mice used included Rpe65450Met, Rpe65450Leu, Rpe65 knockout, Transducin knockout, c–fos knockout, Prion protein (PrP) overexpressing mice, PrP knockouts and Caspase–1 knockouts. Retinal degeneration was monitored by light–microscopy and rhodopsin quantification at 3, 4, 6 and 8 weeks of age. Results: Retinas of VPP mice on the Rpe65450Leu background degenerated faster than those on the Rpe65450Met background. Dark–rearing of VPP;Rpe65450Leu mice attenuated the degeneration. Surprisingly, the Rpe65 knockout did only slow but not protect against degeneration. The degenerative process was not influenced by lack of c–Fos but was slowed by the lack of functional transducin. Overexpression of prion protein improved retinal morphology especially at early timepoints. Similarly, deletion of caspase–1 protease substantially delayed retinal degeneration in the VPP mouse. Conclusions: Rpe65 acts as a modifier gene for retinal degeneration induced by the VPP mutations. Through the modulation of rhodopsin regeneration kinetics, the Rpe65450Leu variant may increase photon absorption capacity by rhodopsin leading to enhanced apoptotic photoreceptor loss. Retinal degeneration in VPP mice may involve phototransduction but may be independent of transcription factor AP–1/c–Fos. Thus, our data suggest that VPP follows – at least in part – the pathway of long–term, low–level light–induced degeneration. Caspase–1 is strongly induced during VPP–mediated degeneration and lack of Caspase–1 substantially delays degeneration suggesting an important role of this protease in the degenerative process. Finally, cellular prion protein may act as a neuroprotective agent in the retina.

Keywords: retinal degenerations: cell biology • neuroprotection • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×